Company expands nationwide eye drop recall

Update:

• Kilitch Healthcare India Ltd. updated its eye drops recall to include the correct National Drug Code (NDC) numbers for two varieties of eye drops sold at Rite Aid.
• The 15-milliliter lubricant gel drops have NDC 11822-4540-5, while the 15-milliliter lubricant eye drops twin pack carries an NDC of 11822-4811-5.
• The Rite Aid eye drop recall is part of a larger recall from Rite Aid, CVS, Target, Walmart, Rugby, Velocity and Leader brands.
• The U.S. Food and Drug Administration found insanitary conditions that could lead to the risk of eye infections or potential harm.
• Distributer Velocity Pharma LLC is notifying wholesalers and retailers of the recall and coordinating the return of impacted products.

Eye drops recall overview: 

• Who: Kilitch Healthcare India Limited recalled a wide range of eye drops sold under the Rite Aid, CVS, Target, Walmart, Rugby, Velocity and Leader brands. 
• Why: The Rite Aid eye drops recall comes after the U.S. Food and Drug Administration found insanitary conditions that could lead to the risk of eye infections or potential harm.
• Where: The eye drops recall is valid across the United States.

(Nov. 22, 2023)

Kilitch Healthcare India Limited issued a recall for eye drops sold under the Rite Aid, CVS, Target, Walmart, Rugby, Velocity and Leaderbrands after the U.S. Food and Drug Administration (FDA) found insanitary conditions that could lead to the risk of eye infections or potential harm.

The eye drops recall comes a week after the FDA warned consumers not to use the eye drops.

The eye drops include these brand names:

• CVS Health
• Equate (Walmart)
• Leader (Cardinal Health)
• Rite Aid
• Rugby (Cardinal Health)
• Target Up & Up
• Velocity Pharma

“For those patients who use these products, there is a potential risk of eye infections or related harm,” the recall says. “These products are intended to be sterile. Ophthalmic drug products pose a potential heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses.”

The recall affects all lots of the eye drops with expiration dates between November 2023 and September 2025.

Consumers can return products to place of purchase, eye drops recall says

Kilitch Healthcare India Ltd. says it has not received reports of adverse effects related to the recall so far. The company is not facing legal action over the recall, but Top Class Actions follows recalls closely as they sometimes lead to class action lawsuits.

Kilitch says it plans to notify distributor Velocity Pharma LLC and will then notify wholesalers and retailers via mail, arranging for return of the eye drops. Consumers should return the eye drops to the place of purchase.

Individuals can contact Kilitch at regulatory@kilitchhealthcare.com or Velocity Pharma at regulatory@velocitypharma.com.

Are you affected by the recall? Let us know in the comments. And be sure to check out our other product recalls. 

Read About More Class Action Lawsuits & Class Action Settlements:

• ResMed issues recall for CPAP masks due to possible magnetic interference
• Homedics initiates recall for massagers due to fire, burn risks
• Equate class action claims blood pressure monitors provide inaccurate, inconsistent readings
• Recall initiated for Americaine 20% Benzocaine Topical Anesthetic Spray due to benzene presence